Global University Venturing

University of Birmingham‘s infectious disease reagent producer Native Antigen Company has been acquired in a deal enabling Mercia Asset Management to exit.

The female entrepreneur-focused social impact firm, which mainly invests at series A and B stage, secured university endowments as LPs for its second fund.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chalmers Ventures head of startups Stina Linge will leave on September 2 to head up Lipidor's animal health products unit Emollivet.

Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.

Sodium-ion battery producer Natron, a Stanford spinout, has picked up corporates ABB and Chevron in a round bringing its lifetime funding to more than $70m.

David Snow, director of University of Arkansas Technology Ventures, has been called upon to lead the Office of Economic Development in an interim capacity.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CAS-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

Baylor College spinout AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

The fund will target early-stage digital health applications, medical devices and therapeutics developed on the Anschutz Medical Campus.